POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.

Pennsylvania House Bill 731 caps fines and court costs at $300 for individuals granted probation without verdict in nonviolent drug offenses

Original title: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for probation without verdict.

Last action · February 25, 2025: Referred to JUDICIARY, Feb. 25, 2025Sponsors: Carol Hill-Evans and 7 others

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Would Do

House Bill 731 caps total fines and court costs at $300 for individuals granted for nonviolent drug offenses in Pennsylvania. The legislation takes effect in 60 days.

Why it matters

Limits the total financial obligation for low-level drug offenders who undergo court-supervised probation and treatment, capping combined court costs and fines regardless of the standard penalties for the underlying offense.

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

Offenders granted probation without verdict

Their total mandatory fines and court costs are capped at $300.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Who is eligible for probation without verdict under this bill?
A person who pleads guilty or to any nonviolent offense under The Controlled Substance, Drug, Device and Cosmetic Act and proves drug dependency through expert testimony.
What is the new financial limit established by the bill?
The total sum of fines and court costs required as a condition of cannot exceed $300.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

1 action
  1. Feb 25, 2025HouseCommittee
    Referred to JUDICIARY, Feb. 25, 2025

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Connected Entities

Pennsylvania Drug, Device and Cosmetic Board, Department of Health
OrganizationPennsylvania Drug, Device and Cosmetic Board“Mentioned in the title/history of the underlying act.”Map →
OrganizationDepartment of Health“Mentioned in the title/history of the underlying act.”Map →

Sources

Open source document

www.palegis.us

Analysis Score

0–100
  • Significance45
    How much this matters to a regular citizen
  • Controversy20
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz15
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record